Greywolf Therapeutics (@greywolfhq) 's Twitter Profile
Greywolf Therapeutics

@greywolfhq

We are advancing novel antigen modulation technology that controls T cells to guide the immune system.

ID: 918015936556396544

linkhttp://greywolftherapeutics.com calendar_today11-10-2017 07:30:29

5 Tweet

1 Followers

0 Following

Greywolf Therapeutics (@greywolfhq) 's Twitter Profile Photo
Greywolf Therapeutics
@greywolfhq

10 months ago

Greywolf Therapeutics Announces Clinical Supply Agreement with Regeneron for Trial Evaluating GRWD5769 in Combination with Libtayo® (cemiplimab)

Greywolf Therapeutics Announces Clinical Supply Agreement with Regeneron for Trial Evaluating GRWD5769 in Combination with Libtayo® (cemiplimab)